17 November 2023
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
First-in-class AKT inhibitor has potential to reshape…
AstraZenecas (AZN) capivasertib gets approval in combination with Faslodex for HR-positive, HER2-negative metastatic breast cancer.…
FDA approves AstraZenecas (AZN) new breast cancer drug, Truqap, and the expanded use of Mercks (MRK) Keytruda in a gastric…
…
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) today anounced that,…
AstraZenecas (AZN) PACIFIC-2 study on Imfinzi fails to achieve statistical significance for the primary endpoint of progression-free survival.…
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat in Studien mit Lungenkrebs-Patienten einen Rückschlag bei einem seiner Kassenschlager erlitten. Eine…
Im Wertpapierhandel ist der Anteilsschein von AstraZeneca zur Stunde unauffällig. Die Aktie notiert derzeit bei 63,37 US-Dollar. Der heutige Börsentag…
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…
…
"The incumbent almost always wins," Jim Cramer said this week.…
AstraZeneca (AZN) beats third-quarter estimates for earnings and sales. The company raises its sales and EPS guidance for 2023.…
To cash in on the rising demand for obesity drugs, AstraZeneca (AZN) in-licenses exclusive rights to ECC5004, a novel oral…
AZN earnings call for the period ending September 30, 2023.…
…
…
AstraZeneca is the latest player to enter the weight loss drug market, which analysts predict could reach $100 billion by…
AstraZeneca CFO Aradhana Sarin discusses the companys third-quarter results and its plans to develop an obesity pill. The treatment developed…
The FTSE 100 gained on Thursday as macroeconomic concerns took a back seat and investors focused on corporate earnings. Upbeat…
9 November 2023 15:00 BST
Director Declaration
AstraZeneca PLC (the Company) today announced that Philip Broadley,senior independent Non-Executive Directorof the Company, has…
The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.…
AstraZeneca PLC (LSE:AZN) has upgraded its sales forecast for the year in the hope that its foray into a semaglutide…
AstraZeneca PLC (LSE:AZN) has upgraded its sales forecast for the year, in the hope that its foray into a semaglutide…
CAMBRIDGE (dpa-AFX) - Astrazeneca hat den Umsatzschwund bei Covid-Arzneien auch im dritten Quartal gut verkraftet. Der britisch-schwedische Pharmakonzern profitierte…
Shares in Virgin Galactic, Bill Holdings, Walt Disney Co, AstraZeneca, Topgolf Callaway, Allbirds, Bill Holdings, and Lyft shares were all…
…
AstraZeneca shares jumped 3% after the Anglo-Swedish drugmaker said it expects its full-year revenues will increase at a higher rate…
AstraZeneca lifts full-year guidance for EPS, revenue despite profit miss…
…
AstraZeneca Plc raised its profit outlook for the year and clinched a deal to develop a drug from the pharma…
09 November 2023
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III…
09 November 2023
AstraZeneca licenses novel agent for the treatment of cardiometabolic conditions and obesity
Global rights to Eccogenes next-generation oral glucagon-like…
AstraZeneca hikes annual profit outlook…
AstraZeneca
9 November 2023
9M and Q3 2023 results
Strong momentum in the year to date leads to increased guidance for Total Revenue…
AstraZeneca reports, Li Auto earnings, Tapestry: 3 things to watch…
…
Viele Unternehmen, unter anderem Merck KGaA, Sony, Astrazeneca, legen heute ihre Zahlen vor. Außerdem stehen wichtige Wirtschaftsdaten aus China, Japan…
The U.S. Federal Trade Commission (FTC) on Tuesday said it sent notice letters to Abbvie , AstraZeneca , Teva and…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends,…
Higher sales of AstraZenecas (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga, are likely to have driven sales in the…
1 November 2023 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
The U.S.-listed shares of Cellectis S.A. CLLS rocketed 179.3% on very heavy volume in premarket trading Wednesday, after the France-based…
…
DJ Astrazeneca investiert 245 Millionen Dollar in Deal mit Cellectis Von Ben Otto LONDON (Dow Jones)--Der britische Pharmakonzern Astrazeneca will…
01 November 2023
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Collaboration leverages the…
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) today announced it…
If approved, AstraZeneca’s nasal spray vaccine would become the first flu vaccine authorized for self-administration in the U.S.…
Employers which pay staff the Real Living Wage (RLW) will have to find an extra 10% after it was increased…
AstraZeneca PLC AZNUK:AZN said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-administered…